Results
94
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
94 companies
Bruker
Market Cap: US$5.6b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$37.40
7D
0.7%
1Y
-41.3%
Dong-A Socio Holdings
Market Cap: ₩720.2b
Engages in the pharmaceutical business in South Korea.
A000640
₩111,900.00
7D
8.1%
1Y
13.0%
Zhejiang Starry PharmaceuticalLtd
Market Cap: CN¥4.7b
Engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally.
603520
CN¥10.80
7D
8.3%
1Y
1.7%
Genovis AB (publ.)
Market Cap: SEK 1.7b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 26.00
7D
-0.6%
1Y
-33.6%
Selvita
Market Cap: zł554.3m
Operates as a contract research organization worldwide.
SLV
zł30.20
7D
-8.2%
1Y
-52.4%
Aroa Biosurgery
Market Cap: AU$160.4m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.47
7D
0%
1Y
-13.9%
Diaceutics
Market Cap: UK£106.9m
A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.27
7D
-9.0%
1Y
-4.5%
ECO Animal Health Group
Market Cap: UK£41.3m
Develops, registers, and markets pharmaceutical products for animals worldwide.
EAH
UK£0.61
7D
0%
1Y
-52.3%
Nanjing Vazyme Biotech
Market Cap: CN¥9.2b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥23.01
7D
7.8%
1Y
2.9%
Knight Therapeutics
Market Cap: CA$572.9m
Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
GUD
CA$5.80
7D
0%
1Y
1.2%
Indoco Remedies
Market Cap: ₹25.7b
Manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally.
INDOCO
₹279.10
7D
12.5%
1Y
-6.4%
Laurus Labs
Market Cap: ₹334.3b
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹619.60
7D
3.0%
1Y
53.3%
Swedencare
Market Cap: SEK 6.3b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 39.55
7D
-0.8%
1Y
-33.3%
AcrobiosystemsLtd
Market Cap: CN¥6.3b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions.
301080
CN¥52.62
7D
3.4%
1Y
35.4%
Hangzhou Bio-Sincerity Pharma-TechLtd
Market Cap: CN¥4.7b
Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd.
301096
CN¥42.93
7D
10.1%
1Y
-30.9%
Jiangxi Synergy Pharmaceutical
Market Cap: CN¥3.4b
Manufactures and sells APIs worldwide.
300636
CN¥8.08
7D
8.9%
1Y
-19.5%
EZZ Life Science Holdings
Market Cap: AU$72.9m
Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.
EZZ
AU$1.55
7D
2.0%
1Y
49.3%
Navamedic
Market Cap: NOK 393.9m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 22.30
7D
1.8%
1Y
-35.4%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥43.0b
Shanghai Allist Pharmaceuticals Co., Ltd.
688578
CN¥95.46
7D
11.0%
1Y
56.5%
Nxera Pharma
Market Cap: JP¥84.8b
Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.
4565
JP¥943.00
7D
15.4%
1Y
-37.1%
Formycon
Market Cap: €439.7m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€24.90
7D
7.1%
1Y
-47.0%
Organogenesis Holdings
Market Cap: US$356.5m
A regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States.
ORGO
US$2.81
7D
-2.1%
1Y
6.0%